Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PRGN-2009 |
| Trade Name | |
| Synonyms | PRGN2009|PRGN 2009 |
| Drug Descriptions |
PRGN-2009 consists of a gorilla adenovirus (GAd) that encodes agonistic HPV E6 and E7 epitopes, which potentially enhances antitumor immune response against HPV-positive tumors and reduces tumor growth (J Immunol 2020, 204 (1 Supplement) 91.6). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C172914 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bintrafusp alfa + PRGN-2009 | Bintrafusp alfa PRGN-2009 | 0 | 1 |
| Cisplatin + Docetaxel + PRGN-2009 | Cisplatin Docetaxel PRGN-2009 | 0 | 1 |
| Pembrolizumab + PRGN-2009 | PRGN-2009 Pembrolizumab | 0 | 2 |
| PRGN-2009 | PRGN-2009 | 0 | 1 |